Mednow Announces Financing by Way of Prospectus Supplement for Proceeds of up to $1,000,000 Led by Gravitas Securities
Mednow Inc. (TSXV: MNOW, OTCQX: MDNWF) has engaged Gravitas Securities Inc. to assist in offering up to 2,325,581 Units at a Unit Price of
- Offering up to 2,325,581 Units could raise up to $1,000,000.
- Funds are intended for working capital and general corporate purposes.
- Warrants provide potential value with a 5-year exercise period.
- Offering is subject to regulatory approval, creating uncertainty.
- Market conditions and capital raising difficulties could impact the Offering.
Not for Distribution to
Each Unit will consist of one Class A common share in the capital of
In consideration for the Agent’s services with respect to the Offering,
It is anticipated that the Proceeds will be used by the Company primarily for working capital and general corporate purposes. The Offering is subject to TSXV approval.
About
To learn more, follow
Neither
Cautionary Statements Regarding Forward-Looking Information:
This news release contains forward-looking information within the meaning of Canadian securities laws. Such information includes, without limitation, information regarding the terms of the Offering and the intended use of proceeds from the Offering. Although
Forward looking information is typically identified by words such as: “believe”, “expect”, “anticipate”, “intend”, “estimate”, “postulate” and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company is not a guarantee of future results or performance and that such forward-looking information is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this news release including, without limitation, that the Offering will close and will do so on the proposed terms; that the Company will be able to utilize the net proceeds of the Offering in the manner intended; that general business and economic conditions will not change in a material adverse manner; that applicable regulatory approvals will be received; and assumptions regarding political and regulatory stability and stability in financial and capital markets.
Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and other factors include, among others: the risk that the Company may not complete the Offering; the risk that the Offering may not be completed on the anticipated terms; the risk that required regulatory approvals for the Offering are not obtained; the state of the financial markets for the Company’s securities; recent market volatility and potentially negative capital raising conditions resulting from the continued COVID-19 pandemic and risks relating to the extent and duration of such pandemic and its impact on global markets; the conflict in
The forward-looking statements contained in this news release are made as of the date of this news release. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within
This news release does not constitute an offer for sale of securities, nor a solicitation for offers to buy any securities.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230424005925/en/
Investor Relations:
ir@mednow.ca
1.855.686.6300
Source:
FAQ
What is Mednow Inc.'s stock symbol?
What is the size of the Offering announced by Mednow?
How much capital does Mednow aim to raise?
What will the proceeds from the Offering be used for?
What is the exercise price of the warrants issued in the Offering?